Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

ImmunoACT announces the approval of India's first CAR-T cell therapy, NexCAR19

Posted On: 2023-10-14 18:44:43 (Time Zone: IST)


Immunoadoptive Cell Therapy Private Limited ("ImmunoACT") received the marketing authorization approval of the first humanized CD19-targeted Chimeric Antigen Receptor T cell (CAR-T cell) therapy product for relapsed / refractory (r/r) B-cell lymphomas and leukemia in India.

NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy. It is the firstof-its kind, a Made-in-India product and puts the nation firmly on the world map of advanced cell-and-gene therapies. ImmunoACT's vision is to provide a high quality and affordable CAR-T cell therapy platform to all sections of the society.

The multi-center Phase I/ II pivotal clinical trial, led by Dr Hasmukh Jain, was conducted with 60 patients of r/r B-cell lymphomas and leukemia. The clinical data indicates ~70% overall response rate (ORR). The safety profile in terms of cytokine release syndrome (CRS) and absence of neurotoxicity indicates a significant improvement over the other commercially approved CD19-directed CAR-T cell therapies. Dr Hasmukh Jain further reiterates, "NexCAR19 has shown an excellent balance of efficacy and low-toxicity, which is a significant advantage in clinical management (post-infusion) of the patients in our resource-constrained settings".

NexCAR19 is the culmination of a collaborative effort across a decade, between the IITBombay, and Tata Memorial Centre (TMC). Dr Atharva Karulkar, Dr Alka Dwivedi and the team led by Dr Rahul Purwar, Associate Professor at IIT Bombay designed and developed the NexCAR19, which subsequently underwent integrative process development & manufacturing under cGMP at ImmunoACT. Clinical investigations and translational studies were led by Dr Hasmukh Jain and Dr Gaurav Narula and their teams at TMH.

Reflecting on the successful completion of clinical trials, Dr Rahul Purwar, Founder & CEO of ImmunoACT says "This is like a dream come true and an incredible win for the patients in the country. Now our patients in India and countries with limited resources will have access to this life-saving drug at an affordable cost. In terms of technical achievement, this is comparable to the moon shot and it puts India on the elite list of select countries that have access to CAR-T therapy".

ImmunoACT is an IIT Bombay incubated company under the aegis of SINE (Society for Innovation and Entrepreneurship) and was founded in 2018 with the intention to be able to translate this academic research into a commercially viable product. As per Shirish Arya, Co-founder, and Director - Strategy & Business Development "ImmunoACT is now poised to become the country's leading multi-product, multi-service cell and gene therapy platform that can significantly change the paradigm of healthcare especially in the area of unmet needs".

Laurus Labs Limited which is a research-driven pharmaceutical and biotechnology company and has a global leadership position in select Active Pharmaceutical Ingredients (APIs) and has been the early backer of ImmunoACT and has invested over USD 18 million to support ImmunoACT to scale its R&D and commercialization efforts. Commenting on this important milestone, Dr Satyanarayana Chava, Founder-CEO of Laurus says "We are very happy and proud to be part of this indigenously developed Cell therapy product for Blood cancer treatment which will help cancer patients in India. This is a fast-evolving technology and we continue to back cutting-edge innovations in the space of cell and gene therapy and new drug discovery".

Tata Memorial Centre (TMC) Mumbai, is India's leading centre for cancer research and treatment center and has played a significant role in the Phase I and Phase II pivotal clinical trials. Dr Gaurav Narula, Professor- Pediatric Oncology, and Dr Hasmukh Jain, Professor - Medical Oncology and their team has been the partner for translational studies and clinical studies. Dr Gaurav Narula is the principal investigator (PI) of an investigator-initiated Phase II clinical trial in the pediatric population.

ImmunoACT intends to make the NexCAR19 (Actalycabtagene autoleucel) therapy available to its partner hospitals as soon as possible.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 404.10 as compared to the previous close of Rs. 401.40. The total number of shares traded during the day was 56552 in over 1831 trades.

The stock hit an intraday high of Rs. 409.00 and intraday low of 399.00. The net turnover during the day was Rs. 22887138.00.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks

ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited

AGI Greenpac Ltd approves ~ Rs. 700 crore capex

NHPC Ltd updates on 300 MW Bikaner Solar Power Project

Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd

Trent Limited crosses operating portfolio of over 1000 fashion stores

Aditya Birla Capital Limited completes amalgamation of Aditya Birla Finance Limited

Cantabil Retail India Ltd opens 13 new showrooms

Kalpataru Projects International Ltd receives orders worth Rs. 621 crores

HCLTech elevates Public Sector expertise with launch of US subsidiary

India Glycols Limited adds 200 KLPD Ethanol capacity

FY 2024-25: Despite Supply Chain Woes, HAL Registers Revenue of Rs 30,400 Crores, Builds Capacities

Loyal Textile Mills Ltd sells part of its windmill units for Rs. 73.80 crores

Aditya Birla Real Estate Ltd streamlines portfolio - Divests Century Pulp and Paper undertaking for Rs. 3498 Cr

Artefact Projects Limited awarded project worth Rs. 241.63 lakh

Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI

Avenue Supermarts Ltd opens 3 new stores, increases store count to 415

Coastal Biotech Pvt Ltd starts trial runs at its Ethanol Plant

Walchandnagar Industries Limited receives contract worth Rs. 30.75 crores

GRSE Records 32 % YoY growth in the FY25

AGI Greenpac Limited to set up new Container Glass Plant in Madhya Pradesh

Triton Valves Limited signs contract with Robert Bosch GmBH

Jyoti Ltd to allot 59,63,636 shares to Rare Asset Reconstruction ltd

Avantel Ltd receives order worth Rs. 11.36 crores

Kohinoor Foods Ltd to sell rice factory for Rs. 190 crores as part of OTS

Aditya Vision Limited opens 4 showrooms at Jharkhand and UP

DCM Shriram Limited commissions new caustic soda flakes plant

Asian Granito India Limited receives IT demand notice

Newgen Software Inc. inks agreement for order worth USD 1,270,000

Blue Jet Healthcare Ltd receives demand notice from IT department for Rs. 1,93,38,55,250/- including interest

LTIMindtree announces strategic partnership with Google Cloud to drive Business Transformation with Agentic AI

NHPC commissions 3 units of Parbati-II HE project

ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings

Engineers India Ltd receives orders worth Rs. 245 crores

Blue Star appoints Mohit Sud as Group President, Unitary Cooling Products

Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21

HBL Engineering Limited receives Kavach contracts worth Rs. 762.56 crores

SPARC announces submission of IND Application for SBO-154 to USFDA

Hon'ble PM Shri Narendra Modi visits Solar Defence and Aerospace Ltd's facilities

Avenue Supermarts Ltd's store count increases to 412, opens 4 new stores today

Tera Software Ltd receives LOIs worth Rs. 273.2 crores from MVVNL

JSW Steel Ltd declared successful bidder by BCCL in the auction of Dugda Coal Washery in the State of Jharkhand

IRM Energy Ltd secures 5-Year RLNG supply agreement with Gujarat State Petroleum Corporation Limited

Uno Minda Strengthens Governance, appoints Ravi Mehra as Managing Director, and Expands Board Expertise

Manoj Vaibhav Gems 'N' Jewellers Ltd opens new Jewellery store at Narsipatnam

Income Tax Authority imposes penalty of Rs. 944.20 crore on InterGlobe Aviation Limited

Tejas Networks Ltd receives Rs. 189.1657 crore under PLI scheme

Nitco Ltd expects Rs. 100 crores on receipt of property from development of Leasehold Rights

Fusion Finance Limited fixes April 4, 2025 as record date for 55:91 rights issue

JM Financial Limited invests in rights issue of JM Financial Asset Management Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020